---
$id: https://graph.org.ai/products/commodity/51111653
$type: Product
source: UNSPSC
code: "51111653"
title: "Tocladesine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tocladesine

**UNSPSC Code**: 51111653
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist and differentiation inducer with the molecular formula C10H11ClN5O6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BQ94Z7E5OR, chemically known as 8-chloroadenosine 3,5-monophosphate but generally known as tocladesine, which bears US NIH Compound Identifier 100299. Most nations schedule tocladesine under HS 29349990 and SITC 51579. As of Q4 2014, TOCLADESINE remains the US FDA Preferred Term for this commodity. Tocladesine bears US NLM identifiers UMLS ID C0050063 and NCI Concept Code C2571. SMILES: C1C2C(C(C(O2)N3C4=C(C(=NC=N4)N)N=C3CL)O)OP(=O)(O1)O.

